137 related articles for article (PubMed ID: 25678551)
1. Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour.
Calvete O; Reyes J; Zuñiga S; Paumard-Hernández B; Fernández V; Bujanda L; Rodriguez-Pinilla MS; Palacios J; Heine-Suñer D; Banka S; Newman WG; Cañamero M; Pritchard DM; Benítez J
Hum Mol Genet; 2015 May; 24(10):2914-22. PubMed ID: 25678551
[TBL] [Abstract][Full Text] [Related]
2. A cumulative effect involving malfunction of the PTH1R and ATP4A genes explains a familial gastric neuroendocrine tumor with hypothyroidism and arthritis.
Calvete O; Herraiz M; Reyes J; Patiño A; Benitez J
Gastric Cancer; 2017 Nov; 20(6):998-1003. PubMed ID: 28474257
[TBL] [Abstract][Full Text] [Related]
3. A knockin mouse model for human ATP4aR703C mutation identified in familial gastric neuroendocrine tumors recapitulates the premalignant condition of the human disease and suggests new therapeutic strategies.
Calvete O; Varro A; Pritchard DM; Barroso A; Oteo M; Morcillo MÁ; Vargiu P; Dodd S; Garcia M; Reyes J; Ortega S; Benitez J
Dis Model Mech; 2016 Sep; 9(9):975-84. PubMed ID: 27491072
[TBL] [Abstract][Full Text] [Related]
4. ECL-cell carcinoids and carcinoma in patients homozygous for an inactivating mutation in the gastric H(+) K(+) ATPase alpha subunit.
Fossmark R; Calvete O; Mjønes P; Benitez J; Waldum HL
APMIS; 2016 Jul; 124(7):561-6. PubMed ID: 27150581
[TBL] [Abstract][Full Text] [Related]
5. A genetic origin for acid-base imbalance triggers the mitochondrial damage that explains the autoimmune response and drives to gastric neuroendocrine tumours.
Benítez J; Marra R; Reyes J; Calvete O
Gastric Cancer; 2020 Jan; 23(1):52-63. PubMed ID: 31250150
[TBL] [Abstract][Full Text] [Related]
6. Correlation between a short-term intravenous octreotide suppression test and response to antrectomy in patients with type-1 gastric neuroendocrine tumours.
Murugesan SV; Steele IA; Dimaline R; Poston GJ; Shrotri M; Campbell F; Varro A; Pritchard DM
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):474-81. PubMed ID: 23249603
[TBL] [Abstract][Full Text] [Related]
7. Dynamic characterization of intestinal metaplasia in the gastric corpus mucosa of Atp4a-deficient mice.
Liu W; Yang LJ; Liu YL; Yuan DS; Zhao ZM; Wang Q; Yan Y; Pan HF
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31904088
[TBL] [Abstract][Full Text] [Related]
8. Gastric achlorhydria in H/K-ATPase-deficient (Atp4a(-/-)) mice causes severe hyperplasia, mucocystic metaplasia and upregulation of growth factors.
Judd LM; Andringa A; Rubio CA; Spicer Z; Shull GE; Miller ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1266-78. PubMed ID: 16048577
[TBL] [Abstract][Full Text] [Related]
9. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
[TBL] [Abstract][Full Text] [Related]
10. Morphological, molecular, and prognostic aspects of gastric endocrine tumors.
Solcia E; Rindi G; Larosa S; Capella C
Microsc Res Tech; 2000 Mar; 48(6):339-48. PubMed ID: 10738315
[TBL] [Abstract][Full Text] [Related]
11. Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer.
Biedermann K; Vogelsang H; Becker I; Plaschke S; Siewert JR; Höfler H; Keller G
J Pathol; 2005 Oct; 207(2):199-206. PubMed ID: 16025435
[TBL] [Abstract][Full Text] [Related]
12. An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.
Majewski IJ; Kluijt I; Cats A; Scerri TS; de Jong D; Kluin RJ; Hansford S; Hogervorst FB; Bosma AJ; Hofland I; Winter M; Huntsman D; Jonkers J; Bahlo M; Bernards R
J Pathol; 2013 Mar; 229(4):621-9. PubMed ID: 23208944
[TBL] [Abstract][Full Text] [Related]
13. Gastric neuroendocrine neoplasms: tumour clonality and malignancy-associated large X-chromosomal deletions.
D'Adda T; Candidus S; Denk H; Bordi C; Höfler H
J Pathol; 1999 Nov; 189(3):394-401. PubMed ID: 10547602
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.
Shimizu T; Marusawa H; Matsumoto Y; Inuzuka T; Ikeda A; Fujii Y; Minamiguchi S; Miyamoto S; Kou T; Sakai Y; Crabtree JE; Chiba T
Gastroenterology; 2014 Aug; 147(2):407-17.e3. PubMed ID: 24786892
[TBL] [Abstract][Full Text] [Related]
15. Alterations in SLC4A2, SLC26A7 and SLC26A9 Drive Acid-Base Imbalance in Gastric Neuroendocrine Tumors and Uncover a Novel Mechanism for a Co-Occurring Polyautoimmune Scenario.
Calvete O; Reyes J; Valdés-Socin H; Martin P; Marazuela M; Barroso A; Escalada J; Castells A; Torres-Ruiz R; Rodríguez-Perales S; Currás-Freixes M; Benítez J
Cells; 2021 Dec; 10(12):. PubMed ID: 34944008
[TBL] [Abstract][Full Text] [Related]
16. Benign glandular downgrowth in gastric neuroendocrine neoplasms: a potential mimic of composite tumour.
Ramineni M; Taggart MW; Rashid A; Abraham SC
Histopathology; 2014 Dec; 65(6):897-907. PubMed ID: 25041266
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
D'Adda T; Keller G; Bordi C; Höfler H
Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic aspects of gastric neuroendocrine tumors.
Rindi G
Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
[TBL] [Abstract][Full Text] [Related]
19. Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets.
Park HY; Kwon MJ; Kang HS; Kim YJ; Kim NY; Kim MJ; Min KW; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Lee HK
Hum Pathol; 2019 May; 87():83-94. PubMed ID: 30851333
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients.
Yoon KA; Ku JL; Yang HK; Kim WH; Park SY; Park JG
J Hum Genet; 1999; 44(3):177-80. PubMed ID: 10319582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
